T cell subsets and their role in the pathogenesis of rheumatic disease

Current Opinion in Rheumatology

Volumn 26, Issue 2, 2014, Pages 204-210

  Gizinski, Alison M ^a   Fox, David A ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

biologic therapeutics; regulatory T cell; TH17

Indexed keywords

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MICE; MYOSITIS; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTE SUBSETS; VASCULITIS;

EID: 84894096187     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000036     Document Type: Review

References (29)

1. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008; 223:87-113
2. Zrioual S, Toh ML, Tournadre A, et al. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 2008; 180:655-663
3. Kato H, Endres J, Fox DA. The roles of IFN-gamma versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts. Modern Rheumatol 2013; 23:1140-1150
4. van Hamburg JP, Corneth OB, Paulissen SM, et al. IL-17/Th17 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis 2013; 72:1700-1707
5. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496:518-522
6. Free ME, Bunch DO, McGregor JA, et al. Patients with antineutrophil cytoplasmic antibody-Associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum 2013; 65:1922-1933
7. Depis F, Hatterer E, Lamacchia C, et al. Long-Term amelioration of established collagen-induced arthritis achieved with short-Term therapy combining anti-CD3 and antitumor necrosis factor treatments. Arthritis Rheum 2012; 64:3189-3198
8. Alzabin S, Abraham SM, Taher TE, et al. Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the Th17 pathway. Ann Rheum Dis 2012; 71:1741-1748
9. Park JS, Lim MA, Cho ML, et al. p53 controls autoimmune arthritis via STATmediated regulation of the Th17 cell/Treg cell balance in mice. Arthritis Rheum 2013; 65:949-959
10. Lee SY, Cho ML, Oh HJ, et al. Interleukin-2/antiinterleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways. Immunology 2012; 137:305-316
11. van Herwijnen MJC, Wieten L, van der Zee R, et al. Regulatory T cells that recognize a ubiquitous stress-inducible self-Antigen are long-lived suppressors of autoimmune arthritis. Proc Natl Acad Sci U S A 2012; 109:14134-14139
12. Kong N, Lan Q, Chen M, et al. Antigen-specific transforming growth factor beta-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. Arthritis Rheum 2012; 64:2548-2558
13. Pieper J, Herrath J, Raghavan S, et al. CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients. BMC Immunol 2013; 14:34
14. Samson M, Audia S, Janikashvili N, et al. Brief report: Inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum 2012; 64:2499-2503
15. McInnes IB, Kavanaugh A, Gottlieb AB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 2013; 382:780-789
16. McGovern JL, Nguyen DX, Notley CA, et al. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to antitumor necrosis factor antibody therapy. Arthritis Rheum 2012; 64:3129-3138
17. Paulissen SMJ, van Hamburg JP, Davelaar N, et al. The COX/prostaglandin-E2 pathway is critical for autocrine IL-17A production by TH17 cells upon synovial fibroblast interaction. Ann Rheum Dis 2012; 71 (Suppl 1):A11
18. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994; 121:484-491
19. Emilie D, Liozon E, Crevon MC, et al. Production of interleukin 6 by granulomas of giant cell arteritis. Human Immunol 1994; 39:17-24
20. Unizony SH, Dasgupta B, Fisheleva E, et al. Design of the tocilizumab in giant cell arteritis trial. Int J Rheumatol 2013; 2013:912562
21. Maeda Y, Seki N, Sato N, et al. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. Int Immunol 2010; 22:515-525
22. Baeten D, Baraliakos X, Braun J, et al. Antiinterleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebo-controlled trial. Lancet 2013; 382:1705-1713
23. Karabiyik A, Peck AB, Nguyen CQ. The important role of T cells and receptor expression in Sjogren's syndrome. Scand J Immunol 2013; 78:157-166
24. Bikker A, Moret FM, Kruize AA, et al. IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Ralpha. Rheumatology 2012; 51:996-1005
25. Truchetet ME, Allanore Y, Montanari E, et al. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis. Ann Rheum Dis 2012; 71:2044-2050
26. Truchetet ME, Brembilla NC, Montanari E, et al. Interleukin-17Acell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 2013; 65:1347-1356
27. Cooney LA, Fox DA. Regulation of th17 maturation by interleukin 4. Crit Rev Immunol 2013; 33:379-387
28. Bekiaris V, Sedy JR, Rossetti M, et al. Human CD4CD3-innate-like T cells provide a source of TNF and lymphotoxin-Alphabeta and are elevated in rheumatoid arthritis. J Immunol 2013; 191:4611-4618
29. Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat CD3CD4-CD8-entheseal resident T cells. Nat Med 2012; 18:1069-1076